Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages

Infection, Genetics and Evolution

Volumn 12, Issue 7, 2012, Pages 1577-1585

  Knetsch, Cornelis W ^a   Terveer, Elisabeth M ^a   Lauber, Chris ^a   Gorbalenya, Alexander E ^a   Harmanus, Céline ^a   Kuijper, Ed J ^a   Corver, Jeroen ^a   van Leeuwen, Hans C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clostridium difficile; Genetic lineages; Genetic markers; MLST; PCR ribotyping; Phylogeny

Indexed keywords

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; EVOLUTIONARY HOMOLOGY; GENE IDENTIFICATION; GENETIC MARKER; GENETIC VARIABILITY; HOUSEKEEPING GENE; MOLECULAR EVOLUTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING; VIRUS TYPING;

BAYES THEOREM; CLOSTRIDIUM DIFFICILE; EVOLUTION, MOLECULAR; GENES, BACTERIAL; GENES, ESSENTIAL; GENETIC VARIATION; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE STANDARDS;

EID: 84865086262     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.06.003     Document Type: Article

References (37)

1. Bakker D., Corver J., Harmanus C., Goorhuis A., Keessen E.C., Fawley W.N., et al. Relatedness of human and animal Clostridium difficile PCR Ribotype 078 isolates based on multi locus variable number of tandem repeat analysis and tetracycline resistance. J. Clin. Microbiol. 2010, 48(10):3744-3749.
2. Bartlett J.G. Antibiotic-associated pseudomembranous colitis. Hosp. Pract. (Off. Ed.) 1981, 16:85.
3. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., Wilcox M.H., Rupnik M., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.
4. Bidet P., Barbut F., Lalande V., Burghoffer B., Petit J.C. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol. Lett. 1999, 175:261-266.
5. Brazier J.S. Typing of Clostridium difficile. Clin. Microbiol. Infect. 2001, 7:428-431.
6. Dingle K.E., Griffiths D., Didelot X., Evans J., Vaughan A., Kachrimanidou M., et al. Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity. PLoS ONE 2011, 6:e19993.
7. Eckert C., Vromman F., Halkovich A., Barbut F. Multilocus variable-number tandem repeat analysis: a helpful tool to subtype French 027 Clostridium difficile isolates. J. Med. Microbiol. 2011, 60 1088-1094.
8. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 2008, 47:1162-1170.
9. Goorhuis A., Debast S.B., Dutilh J.C., van Kinschot C.M., Harmanus C., Cannegieter S.C., et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin. Infect. Dis. 2011, 53:860-869.
10. Griffiths D., Fawley W., Kachrimanidou M., Bowden R., Crook D.W., Fung R., et al. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 2010, 48:770-778.
11. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
12. He M., Sebaihia M., Lawley T.D., Stabler R.A., Dawson L.F., Martin M.J., et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl. Acad. Sci. USA 2010, 107:7527-7532.
13. Hunter P.R., Gaston M.A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 1988, 26:2465-2466.
14. Indra A., Blaschitz M., Kernbichler S., Reischl U., Wewalka G., Allerberger F. Mechanisms behind variation in the Clostridium difficile 16S-23S rRNA intergenic spacer region. J. Med. Microbiol. 2010, 59:1317-1323.
15. Indra A., Huhulescu S., Schneeweis M., Hasenberger P., Kernbichler S., Fiedler A., et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J. Med. Microbiol. 2008, 57:1377-1382.
16. Kelly C.P., Pothoulakis C., LaMont J.T. Clostridium difficile colitis. N. Engl. J. Med. 1994, 330:257-262.
17. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 2008, 46:431-437.
18. Knetsch C.W., Hensgens M.P., Harmanus C., van der Bijl M.W., Savelkoul P.H., Kuijper E.J., et al. Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 2011, 157:3113-3123.
19. Kuehne S.A., Cartman S.T., Heap J.T., Kelly M.L., Cockayne A., Minton N.P. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467:711-713.
20. Kuijper, E.J., Barbut, F., Brazier, J.S., Kleinkauf, N., Eckmanns, T., Lambert, M.L. et al., 2008. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13.
21. Lemee L., Dhalluin A., Pestel-Caron M., Lemeland J.F., Pons J.L. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J. Clin. Microbiol. 2004, 42:2609-2617.
22. Lyras D., O'Connor J.R., Howarth P.M., Sambol S.P., Carter G.P., Phumoonna T., et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458:1176-1179.
23. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 1998, 95:3140-3145.
24. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005, 353:2433-2441.
25. Pepin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile -associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 2005, 41:1254-1260.
26. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile -associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1042.
27. Posada D. JModelTest: phylogenetic model averaging. Mol. Biol. Evol. 2008, 25:1253-1256.
28. Ronquist F., Huelsenbeck J.P. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19:1572-1574.
29. Rupnik M., Brazier J.S., Duerden B.I., Grabnar M., Stubbs S.L. Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 2001, 147:439-447.
30. Schwan C., Stecher B., Tzivelekidis T., van H.M., Rohde M., Hardt W.D., et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog 5 2009, e1000626.
31. Sebaihia M., Wren B.W., Mullany P., Fairweather N.F., Minton N., Stabler R., et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 2006, 38:779-786.
32. Shin B.M., Kuak E.Y. Characterization of a Toxin A-Negative, Toxin B-Positive Variant Strain of Clostridium difficile. Korean J. Lab. Med. 2006, 26:27-31.
33. Shin B.M., Kuak E.Y., Yoo S.J., Shin W.C., Yoo H.M. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn. Microbiol. Infect. Dis. 2008, 60:333-337.
34. Stabler R.A., Dawson L.F., Valiente E., Cairns M.D., Martin M.J., Donahue E.H., et al. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS ONE 2012, 7:e31559.
35. Valiente E., Dawson L.F., Cairns M.D., Stabler R.A., Wren B.W. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J. Med. Microbiol. 2012, 61:49-56.
36. van B.A., Tassios P.T., Dijkshoorn L., Haeggman S., Cookson B., Fry N.K., et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin. Microbiol. Infect. 2007, 13(3):1-46.
37. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 2005, 18:247-263.